Myriad Genetics, Inc. Share Price

Myriad Genetics, Inc. Share Price

MYGN

$6.61

-$0.17 (-2.51%) Last updated on 06 Sep, 2025 | 01:29 IST
  • Performance
  • Chart
  • About
  • Price history
  • FAQs

Myriad Genetics, Inc. Stock Performance

Open
$6.93
Prev. Close
$6.78
Circuit Range
N/A
Day Range
$6.55 - $6.97
Year Range
$3.80 - $29.30
Volume
1,20,197
Average Traded
$6.70

Myriad Genetics, Inc. Share Price Chart

$6.61
Please wait...

About Myriad Genetics, Inc.

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test to help determine the therapy for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; Memorial Sloan Kettering Cancer Center; the University of Texas MD Anderson Cancer Center; the University of Rochester Medical Center; and Flatiron Health, Inc. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Myriad Genetics, Inc. Historical Data

DayOpenCloseChange %
05-Sep-25
$6.93
$6.61
-2.65%
04-Sep-25
$6.75
$6.79
-0.29%
03-Sep-25
$6.86
$6.80
-1.31%
02-Sep-25
$6.42
$6.89
+8.33%
29-Aug-25
$6.21
$6.37
+2.00%
28-Aug-25
$5.98
$6.24
+5.32%
27-Aug-25
$5.81
$5.92
+1.63%

FAQs on Myriad Genetics, Inc. Share Price

Can I buy Myriad Genetics, Inc. shares in India?

chevron-up
Yes. You can buy Myriad Genetics, Inc. in India by opening an international trading account.

What is the share price of Myriad Genetics, Inc.?

chevron-up
As on 07 Sep '25, the share price of Myriad Genetics, Inc. MYGN is $6.61. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.

What is the 5 year returns of Myriad Genetics, Inc.?

chevron-up
The 5 year returns of Myriad Genetics, Inc. is -49.31% as on 07 Sep '25.

What are the high & low stock price of Myriad Genetics, Inc. today?

chevron-up
Myriad Genetics, Inc. stock price hit a high of $6.97 and low of $6.55 as on 07 Sep '25.

What is the 52-week high and low of Myriad Genetics, Inc. stock?

chevron-up
The 52-week high of Myriad Genetics, Inc. stock is $29.30, while the 52-week low is $3.80 as on 07 Sep '25.